What Researchers Did
Researchers reviewed 32 randomized Phase III trials in solid tumours conducted by the British Medical Research Council over a 30-year period, involving over 8000 patients and 5000 deaths.
What They Found
The review encompassed 32 trials involving over 8000 patients and more than 5000 deaths across various solid tumour types including lung, prostate, and ovarian cancers. These trials significantly impacted clinical practice and research, for instance, establishing chemotherapy's role in small cell lung cancer.
What This Means for Canadian Patients
While a historical review, the foundational research from these trials has likely contributed to the evidence base informing current treatment protocols for various solid tumours in Canada. Canadian patients may indirectly benefit from the advancements in clinical practice and research, such as the established role of chemotherapy in small cell lung cancer, that stemmed from these studies.
Canadian Relevance
This study has no direct Canadian connection as it reviews trials conducted by the British Medical Research Council.
Study Limitations
A limitation is that this paper is a historical review of trials up to 1995, meaning the findings may not reflect current treatment paradigms or statistical methodologies.